Suppr超能文献

醛固酮和血管紧张素在速尿处理大鼠钠食欲成熟中的作用。

Roles of aldosterone and angiotensin in maturation of sodium appetite in furosemide-treated rats.

作者信息

Rowland N E, Morian K R

机构信息

Department of Psychology, University of Florida, Gainesville, Florida 32611-2250, USA.

出版信息

Am J Physiol. 1999 May;276(5):R1453-60. doi: 10.1152/ajpregu.1999.276.5.R1453.

Abstract

When rats are treated with furosemide, there is a rapid natriuresis. However, increased sodium appetite does not occur until some time later. One hypothesis to explain this delay is that increased circulating levels of the hormones of sodium depletion prime or sensitize the brain circuits involved in sodium appetite, perhaps by induction of target gene(s). In the present study, we describe the time course of the temporal maturation of sodium appetite after furosemide treatment and the associated changes in plasma levels of ANG II and aldosterone and in plasma volume. Sodium appetite is modest 3 h after furosemide treatment, is increased after 12 h, and is still larger after 24 h. This pattern is evident with repeated testing. Plasma levels of aldosterone and plasma renin activity are substantially increased 3 h after furosemide treatment, and so the NaCl appetite cannot result simply from progressively increasing levels of these hormones. Furthermore, activation of the subfornical organ and the ventral lamina terminalis, assessed with c-Fos immunocytochemistry, did not differ across these three times. Metyrapone, an inhibitor of adrenal steroid synthesis, was used to examine sodium appetite in the absence of elevations in aldosterone after furosemide treatment. Although metyrapone effectively blocked the increase in aldosterone, it was without effect on the appetite 3 or 24 h after furosemide treatment. Furthermore, elevations of plasma aldosterone by the use of minipumps for several days before furosemide treatment did not prime or potentiate but instead tended to inhibit the induced sodium appetite, despite achieving levels of aldosterone and plasma renin activity typically associated with a robust sodium appetite. Infusions of DOCA gave a similar result. Lastly, minipump infusions of ANG II also did not potentiate sodium appetite. Thus neither addition nor subtraction of these hormones alone influenced sodium appetite under these conditions.

摘要

用呋塞米处理大鼠时,会迅速出现利钠作用。然而,直到一段时间后才会出现钠食欲增加的情况。一种解释这种延迟的假说是,钠耗竭激素的循环水平升高使参与钠食欲的脑回路启动或敏感化,可能是通过诱导靶基因实现的。在本研究中,我们描述了呋塞米处理后钠食欲的时间成熟过程以及血浆中血管紧张素II和醛固酮水平及血浆容量的相关变化。呋塞米处理3小时后钠食欲适度,12小时后增加,24小时后更大。这种模式在重复测试中很明显。呋塞米处理3小时后,血浆醛固酮水平和血浆肾素活性大幅增加,因此氯化钠食欲不能仅仅由这些激素水平的逐渐升高导致。此外,用c-Fos免疫细胞化学评估,穹窿下器官和终板腹侧层的激活在这三个时间点并无差异。美替拉酮是一种肾上腺类固醇合成抑制剂,用于在呋塞米处理后醛固酮不升高的情况下检测钠食欲。尽管美替拉酮有效地阻断了醛固酮的增加,但对呋塞米处理3小时或24小时后的食欲没有影响。此外,在呋塞米处理前用微型泵持续几天升高血浆醛固酮,并没有启动或增强而是倾向于抑制诱导的钠食欲,尽管达到了通常与强烈钠食欲相关的醛固酮和血浆肾素活性水平。输注脱氧皮质酮也得到了类似的结果。最后,微型泵输注血管紧张素II也没有增强钠食欲。因此,在这些条件下,单独添加或减去这些激素都不会影响钠食欲。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验